| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMARCA4 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | ALX1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | NUDT2 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | WDR77 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | TXNDC9 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | TTC23 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.07 |
| mRNA | LTA4H | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | TUBGCP4 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | SNRPC | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | SH2D3A | CTRPv2 | pan-cancer | AAC | 0.083 | 0.07 |
